Scrip Interviews: GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets
2019/6/4
GEXVal Inc. June 4th, 2019 Scrip Interviews: GEXVal Focuses On Rare Diseases As It Builds On Ex-Takeda Assets […]
GEXVal Participates in CHINABIO PARTNERING FORUM 2019
2019/4/26
GEXVal Inc. April 26, 2019 GEXVal participates in CHINABIO PARTNERING FORUM 2019 GEXVal will participate in t […]
GEXVal Appeared in Nikkei, Japan’s Largest Financial Paper
2019/4/22
GEXVal Inc. April 22, 2019 GEXVal Appeared in Nikkei, Japan's Largest Financial Paper In an article highlighti […]
GEXVal Participated in the 139th Annual Meeting of the Pharmaceutical Society of Japan
2019/3/20
GEXVal Inc. March 20, 2019 GEXVal participated in the 139th Annual Meeting of the Pharmaceutical Society of Ja […]
GEXVal Gives Presentation at BIO-Asia 2019
2019/1/19
GEXVal Inc. January 19, 2019 GEXVal gives presentation at BIO-Asia 2019 GEXVal will make a presentation to the […]